Telix Pharmaceuticals to acquire Dedicaid to expand AI capabilities
Dedicaid has built an AI-based clinical decision support software (CDSS) platform that produces indication-specific CDSS applications from available…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Apr 23
Dedicaid has built an AI-based clinical decision support software (CDSS) platform that produces indication-specific CDSS applications from available…
26 Apr 23
The accelerated approval has been given by the FDA based on a reduction in plasma NfL shown in…
26 Apr 23
The acquisition is expected to expedite the profitability and diversify revenue streams of the ROLVEDON (eflapegrastim-xnst) injection
25 Apr 23
Baqsimi is a nasally administered glucagon, indicated for the treatment of severe hypoglycaemia (very low blood sugar) in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 Apr 23
Eplontersen, jointly developed by AstraZeneca and Ionis Pharmaceuticals, met all co-primary endpoints and secondary endpoints at 66 weeks…
24 Apr 23
The merger creates a combined company that will operate as GRI Bio and will focus on advancing the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 Apr 23
The introduction of AVAXIM Junior in the UK was based on findings from 20 clinical studies in 14…
21 Apr 23
Moderna will take part in the IBM Quantum Accelerator programme and will join the IBM Quantum Network, while…
21 Apr 23
TPG will acquire a majority interest in the community oncology practice management platform, while AmerisourceBergen will buy a…
21 Apr 23
Mondelēz International, Inc. (Nasdaq: MDLZ), today opened applications for CoLab Tech. The innovative accelerator program is designed to…